Format

Send to

Choose Destination
Horm Metab Res. 2011 Aug;43(9):593-600. doi: 10.1055/s-0031-1284353. Epub 2011 Aug 5.

Prolactin and lactation as modifiers of diabetes risk in gestational diabetes.

Author information

1
Department of Internal Medicine, Division of Endocrinology University of Texas, Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas 75390-8857, Texas, USA. Maria.Ramos-Roman@UTSouthwestern.edu

Abstract

Pregnancy and puerperium are periods of intense hormonal changes. Maternal metabolism adapts to spare the mother from harm on behalf of her developing offspring and major alterations maintain normal glucose tolerance. Insulin secretion increases during a normal pregnancy to compensate for pregnancy-induced insulin resistance and maintain euglycemia. Women at risk for gestational diabetes have insulin resistance before conception. Gestational diabetes develops when a woman at risk is unable to meet the insulin secretory demands imposed by the additional insulin resistance characteristic of pregnancy. The lactogens, human placental lactogen and prolactin, are major stimuli for the adaptation of the endocrine pancreas during gestation. This review discusses the role of lactogens on glucose homeostasis during pregnancy and proposes a mechanism by which the hormonal control of lactation, led by prolactin, may regulate adipocyte biology, glucose and lipid metabolism, and guard postpartum women against type 2 diabetes.

PMID:
21823053
DOI:
10.1055/s-0031-1284353
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center